These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 3517382

  • 1. Phenylbutazone in the horse: a review.
    Tobin T, Chay S, Kamerling S, Woods WE, Weckman TJ, Blake JW, Lees P.
    J Vet Pharmacol Ther; 1986 Mar; 9(1):1-25. PubMed ID: 3517382
    [Abstract] [Full Text] [Related]

  • 2. Population distributions of phenylbutazone and oxyphenbutazone after oral and i.v. dosing in horses.
    Chay S, Woods WE, Nugent TE, Weckman T, Houston T, Sprinkle F, Blake JW, Tobin T, Soma LR, Yocum J.
    J Vet Pharmacol Ther; 1984 Dec; 7(4):265-76. PubMed ID: 6512917
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of phenylbutazone and its metabolites in the horse.
    Gerring EL, Lees P, Taylor JB.
    Equine Vet J; 1981 Jul; 13(3):152-7. PubMed ID: 7297544
    [Abstract] [Full Text] [Related]

  • 4. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
    Lees P, Taylor JB, Maitho TE, Millar JD, Higgins AJ.
    Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
    [Abstract] [Full Text] [Related]

  • 5. The bioavailability of phenylbutazone in the horse.
    Smith PB, Caldwell J, Smith RL, Horner MW, Moss MS.
    Xenobiotica; 1987 Apr; 17(4):435-43. PubMed ID: 3604253
    [Abstract] [Full Text] [Related]

  • 6. Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH.
    Houston T, Chay S, Woods WE, Combs G, Kamerling S, Blake JW, Edmundson AG, Vessiney R, Tobin T.
    J Vet Pharmacol Ther; 1985 Jun; 8(2):136-49. PubMed ID: 4020945
    [Abstract] [Full Text] [Related]

  • 7. The disposition of suxibuzone in the horse.
    Delbeke FT, Vynckier L, Debackere M.
    J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
    [Abstract] [Full Text] [Related]

  • 8. Absorption and pharmacokinetics of phenylbutazone in Welsh Mountain ponies.
    Maitho TE, Lees P, Taylor JB.
    J Vet Pharmacol Ther; 1986 Mar; 9(1):26-39. PubMed ID: 3701913
    [Abstract] [Full Text] [Related]

  • 9. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
    Mills PC, Ng JC, Auer DE.
    J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamics and pharmacokinetics of phenylbutazone in calves.
    Arifah AK, Lees P.
    J Vet Pharmacol Ther; 2002 Aug; 25(4):299-309. PubMed ID: 12213119
    [Abstract] [Full Text] [Related]

  • 11. Bioavailability of phenylbutazone preparations in the horse.
    Rose RJ, Kohnke JR, Baggot JD.
    Equine Vet J; 1982 Jul; 14(3):234-7. PubMed ID: 7106088
    [Abstract] [Full Text] [Related]

  • 12. Absorption of phenylbutazone from a paste formulation administered orally to the horse.
    Lees P, Higgins AJ, Mawhinney IC, Reid DS.
    Res Vet Sci; 1986 Sep; 41(2):200-6. PubMed ID: 3775111
    [Abstract] [Full Text] [Related]

  • 13. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
    Soma LR, Gallis DE, Davis WL, Cochran TA, Woodward CB.
    Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
    [Abstract] [Full Text] [Related]

  • 14. Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse.
    Rees WA, Harkins JD, Woods WE, Blouin RA, Lu M, Fenger C, Holland RE, Chambers TM, Tobin T.
    Equine Vet J; 1997 Mar; 29(2):104-10. PubMed ID: 9104558
    [Abstract] [Full Text] [Related]

  • 15. Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse.
    Lees P, Taylor JB, Higgins AJ, Sharma SC.
    J Vet Pharmacol Ther; 1986 Jun; 9(2):204-12. PubMed ID: 3723663
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses.
    Keegan KG, Messer NT, Reed SK, Wilson DA, Kramer J.
    Am J Vet Res; 2008 Feb; 69(2):167-73. PubMed ID: 18241011
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration.
    Lees P, Ayliffe T, Maitho TE, Taylor JB.
    Res Vet Sci; 1988 Jan; 44(1):57-67. PubMed ID: 3375589
    [Abstract] [Full Text] [Related]

  • 18. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H, Hashem A.
    Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
    [Abstract] [Full Text] [Related]

  • 19. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
    Foreman JH, Ruemmler R.
    Equine Vet J Suppl; 2011 Nov; (40):12-7. PubMed ID: 22082440
    [Abstract] [Full Text] [Related]

  • 20. Effects of ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse.
    Owens JG, Kamerling SG, Stanton SR, Keowen ML.
    Equine Vet J; 1995 Jul; 27(4):296-300. PubMed ID: 8536666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.